1. FRI0445 Efficacy and Safety of Riociguat in Patients with Pulmonary Arterial Hypertension (PAH) Associated with Connective Tissue Disease (CTD): Results from Patent-1 and Patent-2. (9th June 2015) Authors: Denton, C.; Coghlan, J.G.; Ghofrani, H.-A.; Grimminger, F.; He, J.; Riemekasten, G.; Vizza, C.D.; Boeckenhoff, A.; Meier, C.; Nikkho, S.; Pena, J.; Humbert, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0267 Initial Combination Therapy of Ambrisentan and Tadalafil in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH): Subgroup Analysis from the Ambition Trial. (9th June 2015) Authors: Coghlan, J.G.; Galiè, N.; Barbera, J.A.; Frost, A.E.; Ghofrani, H.A.; Hoeper, M.M.; Mclaughlin, V.V.; Peacock, A.J.; Simonneau, G.; Vachiery, J.L.; Blair, C.; Gillies, H.; Harris, J.H.; Langley, J.; Rubin, L.J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗